Product
Tecovirimat
Aliases
Tecovirimat Oral Capsule, TPOXX
5 clinical trials
3 indications
Indication
MonkeypoxIndication
MelioidosisIndication
Molluscum contagiosumClinical trial
A Randomized, Placebo-Controlled, Double-Blinded Trial of the Safety and Efficacy of Tecovirimat for the Treatment of Human Monkeypox Virus DiseaseStatus: Recruiting, Estimated PCD: 2025-05-30
Clinical trial
Placebo-controlled Randomized Trial of Tecovirimat in Non-hospitalized Patients With Monkeypox: Canadian Feasibility Study (PLATINUM-CAN)Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Phase III, Multi-country, Randomized, Placebo-controlled, Double-blinded Trial to Assess the Efficacy and Safety of Tecovirimat Antiviral Treatment for Patients With Monkeypox Virus DiseaseStatus: Recruiting, Estimated PCD: 2024-01-01
Clinical trial
European Randomised Clinical Trial on mPOX InfectionStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Clinical trial
A Randomized, Placebo-controlled, Double-blinded Trial of the Safety and Efficacy of Tecovirimat for the Treatment of Adult and Pediatric Patients With Monkeypox Virus DiseaseStatus: Recruiting, Estimated PCD: 2024-08-01